目的观察舒利迭治疗支气管哮喘的疗效。方法 184例支气管哮喘患者随机分为实验组和对照组,每组92例,对照组给予常规治疗,实验组加用舒利迭治疗,观察两组的治疗效果。结果实验组的总有效率为95.65%,对照组为72.83%,两组相比差异具有统计学意义(P<0.05);在一秒用力呼气容积(FEV1)和最大呼气流量(PEF)方面,两组与治疗前相比差异均具有统计学意义(P<0.05);组间相比,实验组优于对照组,差异有统计学意义(P<0.05)。结论舒利迭治疗支气管哮喘疗效可靠,值得临床推广。 Objective To observe the efficacy of seretide in the treatment of bronchial asthma. Methods A total of 184 patients with bronchial asthma were randomly divided into experimental group and control group, 92 cases in each group. The control group was given routine treatment. The experimental group was treated with seretide and the therapeutic effect was observed. Results The total effective rate was 95.65% in the experimental group and 72.83% in the control group, with significant difference between the two groups (P <0.05). In the forced expiratory volume one second (FEV1) and maximum expiratory flow (PEF) The difference between the two groups was statistically significant (P <0.05). Compared with the control group, the experimental group was superior to the control group, the difference was statistically significant (P <0.05). Conclusion Seretide treatment of bronchial asthma is reliable and worthy of clinical promotion.